Gray Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$251K Sell
9,461
-1,531
-14% -$41.5K 0.1% 111
2024
Q3
$318K Buy
10,992
+419
+4% +$12.2K 0.13% 95
2024
Q2
$296K Buy
10,573
+2,306
+28% +$63.5K 0.13% 97
2024
Q1
$229K Buy
+8,267
New +$229K 0.1% 124
2023
Q4
Sell
-6,457
Closed -$214K 135
2023
Q3
$214K Sell
6,457
-284
-4% -$10K 0.11% 119
2023
Q2
$247K Buy
6,741
+232
+4% +$9.03K 0.12% 104
2023
Q1
$266K Sell
6,509
-977
-13% -$42.2K 0.14% 100
2022
Q4
$384K Buy
7,486
+320
+4% +$15.3K 0.22% 68
2022
Q3
$314K Buy
7,166
+254
+4% +$12.3K 0.2% 75
2022
Q2
$362K Buy
6,912
+614
+10% +$31.3K 0.22% 73
2022
Q1
$326K Buy
6,298
+173
+3% +$8.98K 0.17% 80
2021
Q4
$362K Buy
6,125
+247
+4% +$12.2K 0.18% 78
2021
Q3
$253K Buy
5,878
+375
+7% +$16.6K 0.14% 99
2021
Q2
$216K Sell
5,503
-280
-5% -$10.9K 0.12% 111
2021
Q1
$210K Buy
5,783
+174
+3% +$6.18K 0.13% 105
2020
Q4
$207K Buy
+5,609
New +$206K 0.14% 104

Other funds holding PFE

Gray Wealth Management's PFE Position: Q4 2024 in Review

Gray Wealth Management reduced its Pfizer (PFE) stake by 14% in Q4 2024, selling an estimated $41.5K and leaving 9,461 shares worth $251K. The position accounts for 0.1% of the portfolio, ranked #111.

Gray Wealth Management first reported a position in PFE in Q4 2020 and has held it in 16 quarters since. The position peaked at $384K in Q4 2022. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Gray Wealth Management held 9,461 shares of Pfizer worth $251K as of Q4 2024.
  • Gray Wealth Management sold 1,531 Pfizer shares in Q4 2024, an estimated $41.5K.
  • Pfizer made up 0.1% of Gray Wealth Management's portfolio in Q4 2024, its #111 holding.
  • Gray Wealth Management first reported a position in Pfizer in Q4 2020 and has held it in 16 quarters since.
  • Gray Wealth Management's Pfizer position peaked at $384K in Q4 2022.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Gray Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.